1. Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have been eligible for inclusion in randomized controlled trials (RCT) in the pre-SES and SES era, and (B) would have been eligible for inclusion in randomized controlled trials in the pre-SES and SES era.
From: The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease
Eur Heart J. 2005;26(7): doi: /eurheartj/ehi088
Eur Heart J | © The European Society of Cardiology All rights reserved. For Permissions, please

2. Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have been eligible for inclusion in randomized controlled trials (RCT) in the pre-SES and SES era, and (B) would have been eligible for inclusion in randomized controlled trials in the pre-SES and SES era.
From: The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease
Eur Heart J. 2005;26(7): doi: /eurheartj/ehi088
Eur Heart J | © The European Society of Cardiology All rights reserved. For Permissions, please

3. Figure 2 (A) Cumulative revascularization percentages, and (B) cumulative one-year adverse events (death, post-discharge myocardial infarction, revascularization) after CABG and PCI according to the bare-stent (implantation of a bare metal stent in the pre-SES period), pure-stent [only SES(s) implanted without bare metal stents], pre-SES CABG and SES CABG.
From: The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease
Eur Heart J. 2005;26(7): doi: /eurheartj/ehi088
Eur Heart J | © The European Society of Cardiology All rights reserved. For Permissions, please

4. Figure 2 (A) Cumulative revascularization percentages, and (B) cumulative one-year adverse events (death, post-discharge myocardial infarction, revascularization) after CABG and PCI according to the bare-stent (implantation of a bare metal stent in the pre-SES period), pure-stent [only SES(s) implanted without bare metal stents], pre-SES CABG and SES CABG.
From: The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease
Eur Heart J. 2005;26(7): doi: /eurheartj/ehi088
Eur Heart J | © The European Society of Cardiology All rights reserved. For Permissions, please

5. Figure 1 (A) Cumulative death and post-discharge myocardial infarction percentages; (B) cumulative revascularization; and (C) cumulative major adverse cardiac events (death, post-discharge myocardial infarction, revascularization) after revascularization (PCI and CABG combined) according to the pre-SES and SES era 12 months after the index procedure.
From: The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease
Eur Heart J. 2005;26(7): doi: /eurheartj/ehi088
Eur Heart J | © The European Society of Cardiology All rights reserved. For Permissions, please

6. Figure 1 (A) Cumulative death and post-discharge myocardial infarction percentages; (B) cumulative revascularization; and (C) cumulative major adverse cardiac events (death, post-discharge myocardial infarction, revascularization) after revascularization (PCI and CABG combined) according to the pre-SES and SES era 12 months after the index procedure.
From: The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease
Eur Heart J. 2005;26(7): doi: /eurheartj/ehi088
Eur Heart J | © The European Society of Cardiology All rights reserved. For Permissions, please

7. Figure 1 (A) Cumulative death and post-discharge myocardial infarction percentages; (B) cumulative revascularization; and (C) cumulative major adverse cardiac events (death, post-discharge myocardial infarction, revascularization) after revascularization (PCI and CABG combined) according to the pre-SES and SES era 12 months after the index procedure.
From: The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease
Eur Heart J. 2005;26(7): doi: /eurheartj/ehi088
Eur Heart J | © The European Society of Cardiology All rights reserved. For Permissions, please